Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome is a very rare genetic condition that affects growth before birth. Its main features are severe fetal growth restriction, changes in brain development, and fixed joints called contractures. It is usually recognized during pregnancy or at birth, and the early signs of lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome can include a baby measuring much smaller than expected. Family stories sometimes reveal a pattern across generations, but this condition can also happen because of a new genetic change. There is no cure, and treatment is supportive, while survival is usually limited to the pregnancy or the first days to weeks after birth.
How many people live with Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome?
There is no reliable estimate of how many people are living with this condition worldwide; Orphanet lists its frequency as unknown (Orphanet, 2024). There is also no reliable U.S. estimate, and the NIH Genetic and Rare Diseases Information Center does not report a national count (NIH Genetic and Rare Diseases Information Center, 2024).
Overview
Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndromeSymptoms
Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome causes severe poor growth before birth, abnormal brain development, and stiff, fixed joints. Babies are often very small and may have a small head. It is usually fatal before or shortly after birth.
Outlook and prognosis
Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome has a very poor outlook. Because growth before birth is severely limited and the brain and joints are seriously affected, most babies die during pregnancy or soon after birth.
Causes and risk factors
Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome is caused by a harmful gene change, usually inherited from both parents. Risk is highest when both parents carry the same altered gene; lifestyle or environmental factors do not cause it.
Genetic influences
Genetics are central to Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome. It is considered a genetic condition, usually caused by harmful changes in genes important for early fetal development, although the exact gene can vary between affected families.
Diagnosis
Diagnosis of lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome usually starts with ultrasound findings before birth and clinical features at delivery. Doctors may confirm the genetic diagnosis of lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome with genetic tests and sometimes brain imaging.
Treatment and drugs
Treatment for lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome focuses on supportive care. During pregnancy, this often means close monitoring and planning. After birth, care usually centers on comfort, feeding support, breathing support, and family support.
Symptoms
In this rare genetic condition, the main concerns usually begin before birth. Babies with Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome often grow much more slowly than expected in the womb and may move less than usual. The brain does not form in the usual way, and joints can become fixed in bent or stiff positions before birth. These early features of Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome are severe, and many affected babies do not survive pregnancy or the newborn period.
Growth during pregnancy is usually far below what doctors expect for the stage of pregnancy. On ultrasound, the baby may measure much smaller than expected, which can raise concern early.
Many pregnancies involve reduced fetal movement because the baby cannot move as freely as usual. You might notice fewer kicks or stretches, and scans may also show limited motion.
The outer part of the brain may not develop its usual structure and folds. In medical terms, this is a cortical malformation; in everyday life, it means very severe problems with brain development. The head is also often smaller than expected because brain growth is so limited.
Arms and legs may be stuck in fixed positions before birth, a pattern often called congenital contractures. In Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome, this can affect the hands, feet, elbows, knees, or several joints at once.
How people usually first notice Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome?
How Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome is first noticed is usually during pregnancy, when ultrasound shows severe growth restriction, meaning the fetus is much smaller than expected for gestational age, often along with fixed joint contractures and major brain differences. The first signs of Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome are typically found by doctors rather than felt by the pregnant person, because the condition often appears before birth through abnormal prenatal imaging and sometimes reduced fetal movement. After delivery, if the pregnancy continues that far, doctors may also recognize marked growth restriction, congenital contractures, and serious neurologic abnormalities right away.
Types of Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome
Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome is a very rare genetic condition, and doctors do not currently recognize clear, widely accepted disease variants within it. In other words, there are no established types of Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome used in routine medical care or genetics.
No distinct types
No distinct types of Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome are widely recognized. Symptoms can still vary somewhat from one affected pregnancy or infant to another. This variation does not currently define separate clinical variants.
Can I slow down the onset of symptoms?
No. This very rare inherited condition starts before birth, so there is no good evidence that diet, exercise, sleep, supplements, or medicines can meaningfully delay when it begins; research is focused on understanding the gene changes behind it, but there is currently no proven way to slow or prevent its onset in an affected baby. If this condition has affected your family, genetic counseling and family testing can help clarify the chance of it happening again and discuss pregnancy testing options, and while that cannot change the course of the condition, it can give you clearer information and support.
What genetics can tell you about symptoms
Because this syndrome is extremely rare, genetics can confirm the diagnosis, but there is only limited information on how different genetic changes affect the exact symptom pattern in each family. In general, the condition causes severe problems that begin before birth, and the known genetic changes are linked with major growth restriction, brain development differences, and joint contractures, but doctors cannot yet reliably use genetics alone to predict exactly which features will be most prominent or how severe they will be in an individual pregnancy.
Causes and risk factors
A rare harmful gene change present from the start of pregnancy is thought to cause Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome. The main risk is when both parents carry the same altered gene, so family history can matter. Parents who are related by blood or who share a small ancestry group may be more likely to carry the same rare change. Lifestyle, diet, or routine activities in pregnancy are not known to be the primary cause, though overall maternal health can still affect pregnancy outcomes. Genetic testing for Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome can sometimes clarify your personal risk.
What are the most common causes or risk factors?
This condition is most often caused by a rare inherited gene change that disrupts a baby's growth and early brain, muscle, and joint development before birth. The clearest risk factor is when both parents carry the same hidden gene change and pass it on, so the chance is higher in families with a previous affected pregnancy or when the parents are related by blood, such as cousins. No common lifestyle, diet, or everyday pregnancy exposure has been clearly shown to cause it.
Environmental and biological risk factors
The environmental and biological risk factors for lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome are not well defined. Doctors often group risks into internal (biological) and external (environmental). For this very rare syndrome, no clear non-inherited trigger has been confirmed, and most published information comes from only a small number of affected pregnancies.
No specific infection, toxin, radiation exposure, or pollutant has been confirmed as an environmental risk factor for this syndrome. The condition is so rare that researchers cannot yet say whether any outside exposure plays a meaningful role.
Maternal illnesses, placental problems, and other pregnancy-related biological factors have not been established as direct risk factors for lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome. These issues can affect fetal growth in general, but current evidence does not show that they specifically lead to this syndrome.
Advanced maternal age, paternal age, and other parental biological characteristics have not been clearly linked to this syndrome. At present, no proven body-based factor in the parents has been shown to reliably increase the chance of it occurring.
Genetic risk factors
Before birth, this syndrome affects growth, brain development, and movement in ways that usually come from an inherited gene change. When people ask about the genetic causes of lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome, the main pattern described so far is autosomal recessive inheritance, meaning a baby inherits one altered copy of the gene from each parent. Parents who carry just one altered copy are usually healthy and may not know they are carriers.
Rare gene variant: Reported cases have been linked to a disease-causing change in a gene needed for early fetal growth and brain development. When both copies of that gene are altered, development can be severely disrupted before birth.
Recessive inheritance: This syndrome most often follows an autosomal recessive pattern. That means a baby must inherit two altered gene copies, one from each parent, to be affected.
Carrier parents: Many parents of an affected baby are healthy carriers with one altered copy and one working copy of the gene. If both parents are carriers, each pregnancy has a 25% chance of the syndrome, a 50% chance of a healthy carrier child, and a 25% chance of a child without the familial variant.
Family history: A previous affected pregnancy or a known disease-causing variant in the family raises the chance in future pregnancies. Family testing can help show who carries the variant and clarify recurrence risk.
Related parents: Parents who are biologically related have a higher chance of carrying the same rare recessive gene change. This makes very rare inherited conditions like lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome more likely.
Lifestyle risk factors
Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome is a congenital disorder, so lifestyle habits do not cause it. However, how lifestyle affects Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome during pregnancy can still matter for maternal health, fetal growth support, and the risk of added complications. In practice, the main lifestyle risk factors for Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome are habits that can further strain an already fragile pregnancy rather than trigger the syndrome itself.
Inadequate calorie, protein, iron, and folate intake can further reduce fetal growth support in a pregnancy already affected by severe intrauterine growth restriction. Good maternal nutrition will not prevent the syndrome, but it may help avoid additional stress from anemia, low maternal weight gain, or poor placental function.
Cigarette smoking and nicotine use can lower placental blood flow and oxygen delivery to the fetus. In this syndrome, that may worsen growth restriction and increase the chance of added pregnancy complications.
Alcohol does not cause this genetic condition, but it can add extra harm to fetal brain development and growth. In a fetus already affected by cortical malformation and severe developmental problems, alcohol may further reduce fetal reserve.
Recreational drugs such as cocaine, methamphetamine, or opioids can impair placental function, reduce oxygen supply, and raise the risk of preterm delivery. These effects may compound the severity of an already high-risk pregnancy affected by this syndrome.
Risk prevention
Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome is a very rare genetic condition that begins before birth, so there is no known way to prevent the syndrome itself through lifestyle changes or routine medical care. For families with a past affected pregnancy, prevention usually means understanding recurrence risk, planning future pregnancies, and using genetic testing options when available. Because this condition is severe and often identified during pregnancy, care focuses on early recognition, informed decision-making, and support for the pregnant person and family. Different people need different prevention strategies—there’s no single formula.
If this syndrome has happened in a family before, meeting with a genetics specialist before pregnancy can help clarify the chance of it happening again. This can guide decisions about testing, timing, and pregnancy planning.
When possible, testing the baby and parents after an affected pregnancy may identify the specific genetic change involved. Knowing the cause can make future prevention more precise, especially when discussing reproductive options.
In some families, parents may be able to have blood testing to see whether they carry a gene change linked to the condition. This is most useful after a genetic cause has already been found in the family.
Some couples choose in vitro fertilization with embryo testing if the family gene change is known. This may lower the chance of another affected pregnancy, but it is not available or suitable for everyone.
Can you prevent Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome?
No, this condition usually cannot be prevented, because it is a very rare genetic condition that develops before birth and is not caused by anything a parent did or did not do. If there is a family history of it, meeting with a genetics specialist before or during pregnancy may help you understand the chance of it happening again and what testing options are available, but it cannot guarantee prevention.
Transmission
Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome is not infectious, so it cannot be caught or passed from one person to another through touch, air, food, or everyday contact. Instead, it is a genetic condition that is present from conception.
In reported families, Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome appears to follow an autosomal recessive pattern, which means a baby is affected when they inherit a nonworking copy of the related gene from each parent; the parents are usually healthy carriers. If you are wondering how Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome is inherited in your family, genetic counseling can help explain carrier testing and the chance of it happening again in another pregnancy.
When to test your genes
Genetic testing is most useful before or during pregnancy if there is a family history, a previously affected pregnancy, or prenatal ultrasound shows severe growth restriction, brain malformations, or congenital contractures. In this syndrome, testing mainly helps confirm the diagnosis, clarify recurrence risk, and guide reproductive planning rather than customize treatment.
Diagnosis
Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome is usually suspected before birth or at delivery because the pattern of severe growth restriction, brain changes, and fixed joint contractures is often striking. The diagnosis is based on clinical features and imaging findings, then confirmed with specialized genetic testing when possible. Getting a diagnosis is often a turning point toward answers and support.
Doctors may first suspect this condition during pregnancy when ultrasound shows very poor growth before birth and multiple joints that stay fixed in bent positions. Brain differences or reduced fetal movement may also raise concern.
A fetal MRI can give a closer look at the developing brain when ultrasound suggests a cortical malformation. This can help show abnormal folding or structure of the brain and support the diagnosis of lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome.
After birth or following pregnancy loss, doctors examine the baby for severe growth restriction, congenital contractures, and other visible features that fit the syndrome. The overall pattern matters more than any single finding.
Imaging findings or examination of the brain may show major problems in how the cortex formed. These changes help distinguish this syndrome from other causes of early growth restriction and joint contractures.
How is Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome diagnosed?
Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome is usually suspected during pregnancy when ultrasound shows that the baby is much smaller than expected, has very limited movement, has joints stuck in bent positions, and has signs that the brain did not form in the usual way; a fetal MRI can sometimes show the brain changes more clearly. Doctors confirm the diagnosis by putting together the scan findings with the baby’s physical features after delivery or pregnancy loss, and genetic testing may be used to look for the gene change causing it.
Stages of Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome
Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome does not have defined progression stages. That is because it is a severe condition that is present before birth and is identified by a pattern of findings during pregnancy or at delivery, rather than by symptoms that steadily change over time. Doctors usually start with a conversation about pregnancy history and ultrasound findings, then look at growth, brain development, and joint position to understand whether this syndrome is likely. The diagnosis of lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome may involve prenatal imaging, careful physical examination, and sometimes genetic testing to confirm the cause and help with family counseling.
Outlook and prognosis
The outlook for lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome is extremely poor, with severe growth restriction and major brain and musculoskeletal abnormalities leading to death before birth or shortly after delivery in most reported cases. Pregnancy may end in intrauterine fetal demise, or affected newborns may survive only briefly because of the overall severity of the malformations and medical instability. No curative treatment is available, and care is generally focused on supportive management and family-centered decision-making. Because the condition is so rare, the exact survival range is not well defined, but long-term survival has not been reported. Families benefit from early counseling with maternal-fetal medicine, neonatology, and genetics specialists to discuss prognosis, recurrence risk, and options for future pregnancies.
Long-term effects
For families facing lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome, the outlook is sadly very poor. This condition is typically fatal before birth or shortly after delivery, so there are usually no long-term childhood or adult effects to describe. Instead, the prognosis is shaped by severe problems that develop during pregnancy and around birth.
The most important long-term prognosis is that survival is usually not possible beyond the newborn period. In many reported cases, pregnancy ends in stillbirth or death soon after birth.
Profound poor growth before birth can affect the whole body and is one of the major reasons the condition is so serious. What might seem like early symptoms of lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome on scans often reflects a life-limiting process rather than a problem that stabilizes over time.
Major brain malformations can severely limit basic functions needed for survival, including breathing, feeding, and responsiveness after birth. Because these changes begin before birth, they do not usually lead to a chronic lifelong course but to a very short survival time.
Congenital contractures mean several joints are stiff and fixed in position before birth, which can greatly limit movement. These changes are part of the overall severe pattern and add to the poor prognosis rather than becoming a long-term disability in survivors.
How is it to live with Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome?
Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome is an extremely severe genetic condition that affects growth before birth, brain development, and joint movement, and it is usually not compatible with long-term survival. For families, the lived experience is most often centered on a high-risk pregnancy, difficult decisions, intensive medical monitoring, and profound grief rather than ongoing day-to-day life with a child growing up with the condition. The effects reach far beyond the pregnancy itself, often placing heavy emotional strain on parents, siblings, and loved ones, which is why clear counseling, compassionate care, and bereavement support matter so much.
Treatment and drugs
Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome is a very severe genetic condition, and there is no treatment that can reverse the underlying brain, growth, and joint problems. Care is usually focused on supportive treatment during pregnancy and, if the baby is born alive, comfort-focused care such as help with breathing, feeding, warmth, and relief of distress rather than curative drugs or surgery. Treatment often looks different for each person, but for many families this also includes careful monitoring by maternal-fetal medicine specialists, neonatologists, and palliative care teams to guide decisions and support day-to-day care. Because this condition is usually life-limiting, doctors often talk with families about what to expect, what care matches their wishes, and whether genetic counseling and future pregnancy planning may be helpful.
Can you cure Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome?
No. There is currently no cure for lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome, and because it is a very severe inherited condition, treatment cannot reverse the underlying problem. Care is usually focused on comfort, support for the baby and family, and genetic counseling to help families understand future pregnancy risks.
Non-drug treatment
For families affected by Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome, care usually centers on comfort, daily support, and helping with feeding, breathing, and movement rather than trying to cure the condition. Because this syndrome is typically very severe and often life-limiting before or shortly after birth, non-drug treatment is often tailored to the baby’s needs and the family’s goals. Supportive therapies can ease discomfort, reduce complications, and help parents make informed decisions during pregnancy and after delivery. If a baby survives longer, therapies may be adjusted over time based on symptoms and development.
Comfort-focused care can help with pain, breathing distress, and overall quality of life. This often includes careful positioning, warmth, gentle handling, and support for families making difficult choices.
Many babies with this syndrome cannot feed safely or well because of weak sucking, poor coordination, or severe neurological problems. Feeding plans may include lactation support, special feeding techniques, or tube feeding when that matches the goals of care.
Some newborns need non-drug support such as oxygen, suctioning, or breathing assistance if they have trouble keeping their airway clear. In severe cases, families and clinicians may discuss whether short-term or ongoing ventilator support fits the baby’s expected course.
Gentle stretching, splints, and range-of-motion exercises may help with congenital contractures and make handling, dressing, and positioning easier. Not every approach works the same way, especially when joint stiffness is severe or the baby is medically fragile.
Your genes may have an impact on how drugs work for you
For families affected by lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome, there are no well-established medicines that treat the condition itself, so inherited changes in genes are not usually used to choose a specific drug. Care is generally focused on pregnancy monitoring, comfort care, and support, and at this time there is no clear evidence that the genetic changes linked to this syndrome consistently change how commonly used medicines work. In other words, genetic testing is mainly helpful for confirming the diagnosis and understanding future pregnancy risk, rather than predicting medication response.
Pharmacological treatments
For lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome, there is no known medicine that corrects the underlying genetic problem or reverses the brain, growth, and joint changes. Treatment is usually supportive and depends on what symptoms are present after birth, often in a neonatal intensive care or comfort-care setting. In practice, drug treatment for lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome may include medicines for seizures, pain, breathing distress, or infection rather than a single standard regimen.
There is no approved disease-specific medication for this syndrome. Care teams usually focus on comfort, symptom control, and family goals of care.
If seizures occur, doctors may use anticonvulsant drugs such as phenobarbital or levetiracetam. The choice depends on the baby’s condition, response, and overall treatment plan.
Medicines such as acetaminophen and, when needed, opioids like morphine may be used to ease pain or distress. This can matter if contractures, procedures, or serious illness cause discomfort.
If there is severe agitation or breathing distress, medicines such as midazolam may be used for comfort. Dosing is tailored very carefully because these drugs can also affect breathing and alertness.
Genetic influences
Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome appears to have a strong inherited basis. In the small number of families described, more than one pregnancy has been affected, which points to a pattern called autosomal recessive inheritance. This means both parents may carry the same gene change without being ill themselves; a carrier means you hold the gene change but may not show symptoms. When a baby inherits both changed copies, severe problems with growth before birth, brain development, and joint contractures can occur. Because lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome is extremely rare, the exact gene may not be identified in every family, but genetic counseling and testing, when available, can help clarify the chance of it happening again.
Is Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome genetic?
Genetics are central to Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome. It is considered a genetic condition, usually caused by harmful changes in genes important for early fetal development, although the exact gene can vary between affected families.
Having a genetic risk is not necessarily a diagnosis
Gene variants are a normal part of human biology and are widespread in the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, having a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some cases, though, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For families facing Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome, treatment is usually less about finding the right long-term medicine and more about confirming the diagnosis, planning care during pregnancy, and supporting comfort. The genetic change causing this syndrome has a major effect on how the condition develops, but at this time there is no proven gene-targeted drug that can reverse the underlying brain, growth, or joint problems. Many genetic differences can be managed, but for this condition genetics mainly helps doctors make an accurate diagnosis, avoid tests or treatments that are unlikely to help, and guide discussions about supportive or palliative care. If a baby is born alive, any medicines used are usually chosen for symptom relief and comfort based on the baby’s immediate needs, not on a well-established pharmacogenetic test for drug response. Genetic testing also matters for future family planning, because it can help clarify recurrence risk and whether prenatal testing in a later pregnancy may be possible. In that sense, genetics influences treatment of Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome most strongly by shaping diagnosis, care decisions, and counseling rather than by directing a specific medication plan.
Interactions with other conditions
Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome causes severe problems before birth, so the main concern is usually not how it interacts with later diseases, but how its many features affect the whole body at the same time. In practice, the poor growth, brain malformation, and fixed joint contractures can occur alongside other serious newborn problems such as breathing difficulty, feeding failure, or infections, which may further worsen a baby’s condition. Doctors call it a comorbidity when two conditions occur together, but for this syndrome there are no well-established, disease-specific links with common adult illnesses because affected pregnancies and newborns are so severely impacted. Some may find that the signs look similar to other genetic or developmental conditions that also cause severe growth restriction or early symptoms of congenital contractures, so careful evaluation is important to tell them apart. Families facing this diagnosis usually need coordinated care focused on the baby’s immediate medical needs rather than management of long-term disease overlap.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome?
Doctors may also consider other rare conditions that cause very poor growth before birth, problems with brain development, and stiff or fixed joints, especially fetal akinesia sequence, also called Pena-Shokeir syndrome, and some forms of arthrogryposis, which means joints do not move normally before birth. Certain chromosome conditions, especially trisomy 18, and serious infections during pregnancy such as cytomegalovirus or Zika can sometimes cause a similar pattern. Other rare genetic conditions that affect the brain and muscles before birth can also look alike, so detailed scans and genetic testing are often needed to tell them apart.
History
For many families, the first signs appear during pregnancy, when an ultrasound shows that a baby is much smaller than expected and may also have changes in the way the brain or limbs are developing. Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome is a very rare condition, so its history is not one of long-standing public recognition, but of careful medical observation built from a small number of reported pregnancies. In recent decades, awareness has grown as specialists compared similar findings and realized they were seeing a distinct pattern rather than unrelated problems.
Early reports focused on what doctors could see before birth or at delivery: severe growth restriction in the womb, differences in the brain’s structure, and joints that were fixed in bent positions, known as congenital contractures. Because the condition is so uncommon, the medical understanding of it has developed slowly. Many living with more common growth or movement conditions may have some overlapping features, which is one reason rare syndromes like this can take time to recognize and describe clearly.
As imaging improved, especially detailed prenatal ultrasound and later fetal MRI, doctors became better able to connect these findings during pregnancy. This helped shape the current description of the syndrome and made it easier to distinguish it from other causes of early symptoms of severe fetal growth restriction and multiple birth differences. Over time, researchers also confirmed that this syndrome belongs to a group of conditions with an underlying genetic cause, although the exact genetic details are usually discussed separately from the history of how the condition was first recognized.
Today, the history of lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome is still evolving. Most of what is known has come from case reports and small medical series rather than large studies, which is common with very rare disorders. Even so, those early descriptions were important: they helped doctors recognize a consistent pattern, counsel families more accurately, and guide testing and care during pregnancy.